Assessing osteolytic lesion size on sequential CT scans is a reliable study endpoint for bone remineralization in newly diagnosed multiple myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers (2023) 15:15, 4008. https://doi.org/10.3390/cancers15154008
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2024
- Creator
-
Grunz, Jan-Peter
Kunz, Andreas Steven
Baumann, Freerk T.
Hasenclever, Dirk
Sieren, Malte Maria
Heldmann, Stefan
Bley, Thorsten Alexander
Einsele, Hermann
Knop, Stefan
Jundt, Franziska
- DOI
-
10.3390/cancers15154008
- URN
-
urn:nbn:de:bvb:20-opus-362526
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grunz, Jan-Peter
- Kunz, Andreas Steven
- Baumann, Freerk T.
- Hasenclever, Dirk
- Sieren, Malte Maria
- Heldmann, Stefan
- Bley, Thorsten Alexander
- Einsele, Hermann
- Knop, Stefan
- Jundt, Franziska
- Universität Würzburg
Time of origin
- 2024
Other Objects (12)
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
18F-FDG and 11C-methionine PET/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Sleep-disordered breathing in patients with newly diagnosed lung cancer
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
18F-FDG and 11C-methionine PET/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Sleep-disordered breathing in patients with newly diagnosed lung cancer
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
18F-FDG and 11C-methionine PET/CT in newly diagnosed multiple myeloma patients: comparison of volume-based PET biomarkers
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Sleep-disordered breathing in patients with newly diagnosed lung cancer